Stock

Discussion in 'Antares Pharma' started by anonymous, Jul 8, 2021 at 9:03 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Why can’t this stock get above 5. The testosterone product is obviously doing well. It has not moved in 4 years. It is a disgrace that this management team is still in place. I looked at their holdings and the Board and Management give themselves restricted stock and cash it in when it gets to 4.50 and above. Meanwhile shareholders get screwed. Public companies are not in business to enrich the Board and Management. There should be a shareholder lawsuit.
     

  2. anonymous

    anonymous Guest

    Xyosted sales have been flat, this stock/company/management all blow
     
  3. anonymous

    anonymous Guest

    The total market is extremely overvalued. A crash would put significant pressure on shares. That might be a good time to buy ATRS for the longterm. Too risky right now.
     
  4. anonymous

    anonymous Guest

    it is the CEO. He is making himself rich. How come no one looks into this financial fraud.
     
  5. anonymous

    anonymous Guest

    facts are facts. the only shareholders that make any money with this stock are those that trade it. If you held over time you just rode a rollercoaster and didn't make money. Until this changes the facts are only trade shares within a range.
     
  6. anonymous

    anonymous Guest

    Get above $5?????? Doesn’t even stay above $4. POS stock and horrible management. Time to short this bitch. Board is asleep at the wheel.
     
  7. anonymous

    anonymous Guest

    One good product that has leveled off and hit its peak it is just going to maintain its minimal market share or maybe grow slightly
    Two other products that are simply not going anywhere in terms of increasing revenue
    Management is what it is
    Stock also will stay flat never see $5 let alone $4
     
  8. anonymous

    anonymous Guest

    Holding shares long term is a mistake here. You buy in the 2s and sell in the 4 to 5 range. The revenues are just threading water. No growth that will stimulate share price. Nocdurna is never going to do anything. Add to this the very toppy market and a disaster in the politics in DC. If you are planning to invest it may be best to wait for a significant market correction that pummels share price before you get in.
     
  9. anonymous

    anonymous Guest

    That’s where you’re wrong!! Nocdurna will send the price sky high!! $20 limit by Q4. Hold the line!!!!
     
  10. anonymous

    anonymous Guest

    now that is funny Henry. I didn’t know ass suckers could be so funny.
     
  11. anonymous

    anonymous Guest


    This is funny! They will never be above $5 because the execs sell their stock…I know this because I remember as an employee not being able to sell until they did…awful.
     
  12. anonymous

    anonymous Guest

    Me too! Execs sell faster when high! It’s awful!